Literature DB >> 31540712

Changes in the telocyte/CD34+ stromal cell and α-SMA+ myoid cell networks in human testicular seminoma.

Mirca Marini1, Lidia Ibba-Manneschi2, Irene Rosa3, Eleonora Sgambati4, Mirko Manetti5.   

Abstract

Telocytes (TCs), also known as CD34+ stromal/interstitial cells, have recently been identified within the connective tissue of a variety of organs including the normal human testis. Testicular TCs appear to constitute a widespread reticular network distributed either in the peritubular or in the intertubular stromal spaces where they have been suggested to play different roles, such as participation to testis morphogenesis, postnatal preservation of the normal tissue/organ three-dimensional structure, and regulation of spermatogenesis and androgen hormone secretion and release. Although increasing evidence indicates that TCs may be involved in the pathophysiology of various diseases, no study has yet reported possible changes in these cells within the stromal compartment of seminoma, one of the most frequent malignant testicular cancers in humans. Therefore, here we carried out the first investigation of the presence and tissue distribution of TCs/CD34+ stromal cells in human testicular seminoma in comparison with normal human testis using either CD34 immunohistochemistry or CD34/CD31 and CD34/α-smooth muscle actin (α-SMA) double immunofluorescence analyses. In seminoma tissue sections, we observed an overall loss of TCs (CD34+/CD31- stromal cells) accompanying a severe degeneration of the normal architecture of seminiferous tubules and stromal tissue associated with dense cellularity increase and presence of interstitial fibrosis. Noteworthy, in the seminoma tissue the disappearance of TCs was paralleled by an expansion of α-SMA+ myoid cells. Moreover, the CD34+/CD31+ blood vessel network was greatly expanded, while steroidogenic Leydig cells were undetectable in seminoma specimens. Since TCs are emerging as important regulators of tissue and organ homeostasis, collectively the present findings indicate that the possible pathophysiologic implications of the loss of TCs in human testicular seminoma should not be further overlooked.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Human testis; Immunohistochemistry; Myoid cells; Seminoma; Stromal cells; Telocytes

Mesh:

Substances:

Year:  2019        PMID: 31540712     DOI: 10.1016/j.acthis.2019.151442

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  4 in total

1.  Telocytes contribute to aging-related modifications in the prostate.

Authors:  Bruno Domingos Azevedo Sanches; Guilherme Henrique Tamarindo; Juliana Dos Santos Maldarine; Alana Della Torre da Silva; Vitória Alário Dos Santos; Maria Letícia Duarte Lima; Paula Rahal; Rejane Maira Góes; Sebastião Roberto Taboga; Sérgio Luis Felisbino; Hernandes F Carvalho
Journal:  Sci Rep       Date:  2020-12-07       Impact factor: 4.379

Review 2.  Telocytes/CD34+ Stromal Cells in Pathologically Affected White Adipose Tissue.

Authors:  Lucio Díaz-Flores; Ricardo Gutiérrez; Ma Pino García; Miriam González-Gómez; Jose Luís Carrasco; Hugo Alvarez-Argüelles; Lucio Díaz-Flores
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

3.  Scleroderma-like Impairment in the Network of Telocytes/CD34+ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis.

Authors:  Irene Rosa; Eloisa Romano; Bianca Saveria Fioretto; Daniele Guasti; Lidia Ibba-Manneschi; Marco Matucci-Cerinic; Mirko Manetti
Journal:  Int J Mol Sci       Date:  2021-11-17       Impact factor: 5.923

Review 4.  Telocytes in Fibrosis Diseases: From Current Findings to Future Clinical Perspectives.

Authors:  Xiao-Jiao Wei; Tian-Quan Chen; Xiao-Jun Yang
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.